Aarti Pharmalabs Ltd Share Price
As on 13 June 2026 at 02:40 IST
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
-16.22%
Over 6 Months
-16.79%
Over 1 Year
-32.12%
Over 3 Years
60.86%
Aarti Pharmalabs Ltd Summary
Close ₹622.35
Open ₹620
High ₹634.45
Low ₹616.65
Volume 1,40,495
Net Turnover (in Cr) ₹8.79
52Wk High ₹971
52Wk Low ₹585
52Wk High / Low
585
971
Aarti Pharmalabs Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹5,642.09
EPS (TTM) 19.67
Book Value (BV) 218.66
Div. Yield 0.56 %
P/E (TTM) 31.98
Price/Book Value 2.84
Delivery % 51.89 %
Face Value 5
Key Ratios
PE Ratio 26.37
PB Ratio 3.68
EV to Sales 4.06
PEG Ratio 0.93
ROA 11.30
ROE 14.85
Debt-Equity 0.20
Net Profit Margin 14.53
Operating Profit Margin 24.90
Aarti Pharmalabs Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 2,125.19 | 1,857.50 | 1,947.55 | 1,202.46 | - |
| Total Expenses | 1,764.50 | 1,557.01 | 1,686.78 | 1,047.08 | 0 |
| Profit Before Tax | 360.69 | 300.49 | 260.77 | 155.38 | -0 |
| Profit After Tax | 272.40 | 216.90 | 193.49 | 122.25 | -0 |
| Operating Profit After Depreciation | 387.59 | 317.71 | 281.83 | 167.34 | -0 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 1,204.34 | 1,091.75 | 965.50 | 804.23 | - |
| Total Non Current Assets | 1,584.24 | 1,236.46 | 1,081.02 | 1,011.75 | - |
| Total Current Assets | 1,322.17 | 1,345.64 | 1,163.01 | 1,028.15 | 0.25 |
| Total Assets | 2,906.41 | 2,582.11 | 2,244.02 | 2,039.90 | 0.25 |
| Total Shareholder's Fund | 1,989.91 | 1,757.04 | 1,558.49 | 1,386.48 | 0.23 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 331.56 | 216.35 | 250.12 | -43.70 | - |
| Net Cash Used In Investing Activities | -413.90 | -214.56 | -157.80 | -138.74 | - |
| Net Cash Used In Financing Activities | 65.44 | 9.72 | -163.46 | 260.38 | - |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,785.84 | 1,513.14 | 1,512.53 | 943.53 | - |
| Total Expenses | 1,449.50 | 1,238.62 | 1,279.17 | 809.81 | 0 |
| Profit Before Tax | 336.34 | 274.52 | 233.36 | 133.73 | -0 |
| Profit After Tax | 257.35 | 200.65 | 171.73 | 106.73 | -0 |
| Operating Profit After Depreciation | 361.97 | 291.15 | 253.84 | 145.07 | -0 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 1,127.09 | 1,011.75 | 888.06 | 723.26 | - |
| Total Non Current Assets | 1,510.81 | 1,162.85 | 1,010.15 | 936.56 | - |
| Total Current Assets | 1,212.80 | 1,134.06 | 966.22 | 890.27 | 0.25 |
| Total Assets | 2,723.61 | 2,296.91 | 1,976.37 | 1,826.83 | 0.25 |
| Total Shareholder's Fund | 1,843.87 | 1,621.46 | 1,438.58 | 1,284.28 | 0.23 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 340.01 | 183.69 | 215.88 | -64.84 | - |
| Net Cash Used In Investing Activities | -419.80 | -184.40 | -115.55 | -133.54 | - |
| Net Cash Used In Financing Activities | 78.63 | 4.40 | -156.53 | 254.63 | - |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 582.64 | 432.27 | 418.33 | 386.19 | 563.78 |
| Total Expenses | 469.51 | 329.96 | 344.26 | 292.75 | 418.15 |
| Profit Before Tax | 81.67 | 62.87 | 38.68 | 65.46 | 114.62 |
| Profit After Tax | 61.12 | 47.96 | 27.92 | 49.50 | 88.34 |
| Operating Profit after Depreciation | 126.69 | 106.86 | 74.12 | 95.04 | 144.02 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 579.70 | 425.25 | 417.29 | 375.31 | 529.62 |
| Total Expenses | 462.62 | 322.31 | 343.30 | 280.18 | 386.50 |
| Profit Before Tax | 82.59 | 58.58 | 41.71 | 67.18 | 113.49 |
| Profit After Tax | 62.03 | 43.84 | 30.93 | 51.22 | 88.85 |
| Operating Profit after Depreciation | 127.61 | 102.57 | 77.14 | 96.73 | 140.61 |
Aarti Pharmalabs Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 614.52
S2 606.68
S3 596.72
Pivot 624.48
R1 632.32
R2 642.28
R3 650.12
Moving Average
20 SMA 665.94
50 SMA 687.01
100 SMA 703.25
200 SMA 751.90
Aarti Pharmalabs Ltd Corporate Actions
Aarti Pharmalabs Ltd
₹1.5/Share
Announcement Date 16 Feb 2026
Record Date 16 Feb 2026
Div Yield 30%
Aarti Pharmalabs Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
Aarti Pharmalabs Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| Unifi Flexi Cap Fund | 1.39% |
| WhiteOak Capital Pharma and Healthcare Fund | 0.96% |
| Taurus Flexi Cap Fund | 0.81% |
| UTI-Healthcare Fund | 0.78% |
| ICICI Pru Export and Services Fund | 0.46% |
Aarti Pharmalabs Ltd News
Board of Aarti Pharmalabs recommends final dividend
Of Rs 2 per share
26 May 2026, 10:53 am
Aarti Pharmalabs revises board meeting date
To 25 May 2026
18 May 2026, 12:14 pm
Aarti Pharmalabs announces board meeting date
On 18 May 2026
12 May 2026, 10:22 am
Aarti Pharmalabs gets one observation from US FDA post Tarapur unit inspection
Aarti Pharmalabs said that the United States Food and Drug Administration (US FDA) has completed an inspection of its Unit-IV facility located in Tarapur, Maharashtra.
30 Mar 2026, 11:07 am
Aarti Pharmalabs reports minor chemical leakage incident at Tarapur Plant
Aarti Pharmalabs has reported a minor industrial incident at its Unit-VI facility located in Tarapur MIDC, Maharashtra on 22 March 2026.
24 Mar 2026, 02:22 pm
Aarti Pharmalabs Ltd Stock Analysis
- Annual revenue for Aarti Pharmalabs Ltd increased by 18.02% to ₹1,785.84 crore in FY 2025 from ₹1,513.14 crore in FY 2024.
- Annual Net Profit for Aarti Pharmalabs Ltd increased by 28.26% to ₹257.35 crore in FY 2025 from ₹200.65 crore in FY 2024.
- Promoter Shareholding in Aarti Pharmalabs Ltd decreased by 0.03% in the most recent quarter, from 43.10% in December 2025 to 43.08% in March 2026.
- Aarti Pharmalabs Ltd delivered a 1-year return of -32.12% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
- Aarti Pharmalabs Ltd share price moved up by 1.25% from its previous close of INR ₹622.35. The latest Aarti Pharmalabs Ltd share price is INR ₹630.15.
- Aarti Pharmalabs Ltd share price today has been at a low of 625.05 and a high of 631.45. Over the past 52 weeks, the Aarti Pharmalabs Ltd share price has seen a low of 585 and a high of 971.
FAQ’s
What is the share price of Aarti Pharmalabs Ltd today?
Aarti Pharmalabs Ltd share price as on 12 Jun 2026 is ₹ 630.15
What is the Market Cap of Aarti Pharmalabs Ltd?
The market cap of Aarti Pharmalabs Ltd stock is ₹5,642.09 Cr.
What is the PE Ratio of Aarti Pharmalabs Ltd?
The Price to Earnings (P/E) Ratio of Aarti Pharmalabs Ltd is 26.37
What is the PB Ratio of Aarti Pharmalabs Ltd?
The Price to Book (P/B) Ratio of Aarti Pharmalabs Ltd is 3.68
What is the 52 week high of Aarti Pharmalabs Ltd Share Price?
The 52 week high of Aarti Pharmalabs Ltd share price stands at ₹971
What is the 52 week low of Aarti Pharmalabs Ltd Share Price?
The 52 week low of Aarti Pharmalabs Ltd share price stands at ₹585
How can I buy shares of Aarti Pharmalabs Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Aarti Pharmalabs Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
